https://ift.tt/eA8V8J India’s apex drug regulator has allowed Pune-based Serum Institute of India to conduct late-stage — Phase 2 and 3 — human trials in India for the Oxford University Covid-19 vaccine candidate.
from RSS feed https://ift.tt/39ZeN7J
via IFTTT
from RSS feed https://ift.tt/39ZeN7J
via IFTTT
Serum gets DCGI nod for Phase 2 & 3 trials
![Serum gets DCGI nod for Phase 2 & 3 trials]()
Reviewed by Manish Pethev
on
August 04, 2020
Rating:
No comments:
If you have any suggestions please send me a comment.